Meeting of the National Vaccine Advisory Committee, 21368-21369 [E9-10668]

Download as PDF 21368 Federal Register / Vol. 74, No. 87 / Thursday, May 7, 2009 / Notices • Address • Comments such as a personal story of the effect on them of the economic downturn. While it is possible that the comments contain identifiable information they cannot be used as a searchable index. AUTHORITY FOR MAINTENANCE OF THE SYSTEM: The American Recovery and Reinvestment Act of 2009 (Pub. L. 111– 5, Title XV, Section 1526) establishes recovery.gov. PURPOSE: GSA proposes to establish a new system of records subject to the Privacy Act of 1974 (as amended), 5 U.S.C. 552a. The system will collect contact information to provide updates and other important stimulus information to subscribers. The information may be used in conjunction with voluntarily supplied reports to further identify the source (by first name and geographical location). Anonymous aggregations may be used to understand regional trends and/or other statistical analyses. The information will only be used as discussed. Those having access to the information are system administrators and GSA staff and contractors and White House and Recovery Board officials with a strict need to know. ROUTINE USES OF THE SYSTEM RECORDS, INCLUDING CATEGORIES OF USERS AND THEIR PURPOSE FOR USING THE SYSTEM: Information from this system may be disclosed as a routine use by the following: a. System information may be accessed by system managers, technical support and designated analysts in the course of their official duties. The White House, Recovery Board officials and other authorized personnel may access demographic information to understand constituents’ economic needs. They may access information to send emails to those who have signed up for this service. b. Stories provided by individuals may be selected for publication and used in speeches or other discussions related to the stimulus and economic recovery. The only identification will be the user’s first name and state of residence. c. In any legal proceeding, where pertinent, to which GSA is a party before a court or administrative body. d. To authorized officials engaged in investigating or settling a grievance, complaint, or appeal filed by an individual who is the subject of the record. e. To a Federal, State, local, or foreign agency responsible for investigating, VerDate Nov<24>2008 17:03 May 06, 2009 Jkt 217001 prosecuting, enforcing, or carrying out a statute, rule, regulation, or order when GSA becomes aware of a violation or potential violation of civil or criminal law or regulation. f. To an appeal, grievance, hearing, or complaints examiner; an equal employment opportunity investigator, arbitrator, or mediator; and an exclusive representative or other person authorized to investigate or settle a grievance, complaint, or appeal filed by an individual who is the subject of the record. g. To a Member of Congress or his or her staff on behalf of and at the request of the individual who is the subject of the record. h. To an expert, consultant, or contractor of GSA in the performance of a Federal duty to which the information is relevant. i. To appropriate agencies, entities, and persons when (1) the Agency suspects or has confirmed that the security or confidentiality of information in the system of records has been compromised; (2) the Agency has determined that as a result of the suspected or confirmed compromise there is a risk of harm to economic or property interests, identity theft or fraud, or harm to the security or integrity of this system or of other systems or programs (whether maintained by GSA or another agency or entity) that rely upon the compromised information; and (3) the disclosure made to such agencies, entities, and persons is reasonably necessary to assist in connection with GSA’s efforts to respond to the suspected or confirmed compromise and prevent, minimize, or remedy such harm. j. To the National Archives and Records Administration (NARA) for records management purposes. POLICIES AND PRACTICES FOR STORING, RETRIEVING, ACCESSING, RETAINING, AND DISPOSING RECORDS IN THE SYSTEM: STORAGE: Records are stored on a secure server and accessed only by authorized personnel. RETRIEVABILITY: Records may be retrievable by name, email address, or any other personal information listed in the Categories of Records in the System except for personal story. SAFEGUARDS: System records are safeguarded in accordance with the requirements of the Privacy Act. Access is limited to authorized individuals with passwords, and the database is maintained behind PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 a firewall certified by the National Computer Security Association. RETENTION AND DISPOSAL: System records are retained and disposed of according to GSA records maintenance and disposition schedules and the requirements of the Recovery Board and the National Archives and Records Administration. SYSTEM MANAGER AND ADDRESS: Director, Acquisition Environment Division, General Services Administration, 2011 Crystal Drive, Suite 911, Arlington, VA 22202. NOTIFICATION PROCEDURE: Individuals wishing to inquire if the system contains information about them should contact the system manager listed above. RECORD ACCESS PROCEDURE: Requests for access also may be directed to the system manager. CONTESTING RECORD PROCEDURES: Rules for contesting the content of a record and appealing a decision are contained in 41 CFR 105–64. RECORD SOURCE CATEGORIES: The sources for information in the system are the users themselves. [FR Doc. E9–10411 Filed 5–6–09; 8:45 am] BILLING CODE 6820–34–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee AGENCY: Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice of meeting. SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. Preregistration is required for both public attendance and comment. Individuals who wish to attend the meeting and/or participate in the public comment session should either e-mail nvpo@hhs.gov or call 202–690–5566 to register. DATES: The meeting will be held on June 2, 2009, from 9 a.m. to 5:30 p.m. and on June 3, 2009, from 8:30 a.m. to 1:30 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey E:\FR\FM\07MYN1.SGM 07MYN1 21369 Federal Register / Vol. 74, No. 87 / Thursday, May 7, 2009 / Notices Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ms. Andrea Krull, Public Health Advisor, National Vaccine Program Office, Department of Health and Human Services, Room 443–H Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201. Phone: (202) 690–5566; Fax: (202) 260– 1165; e-mail: nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. Topics to be discussed at the meeting include vaccine safety recommendations, the National Vaccine Plan, adult immunization recommendations, NVAC evaluation, vaccine stockpile, vaccine financing, 2009 H1N1 influenza outbreak, and other related issues. The meeting agenda will be posted on the Web site: https:// www.hhs.gov/nvpo/nvac by May 18, 2009. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person at least one week prior to the meeting. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Individuals who would like to submit written statements should e-mail or fax their comments to the National Vaccine Program Office at least five business days prior to the meeting. Register by sending an e-mail to nvpo@hhs.gov or by calling 202–690– 5566 and providing name, e-mail address and organization. be received within 60 days of this notice. Dated: April 29, 2009. Bruce Gellin, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office. [FR Doc. E9–10668 Filed 5–6–09; 8:45 am] Tremolite Asbestos Registry (TAR) OMB# 0923–0039—Extension—Agency for Toxic Substances and Disease Registry, (ATSDR) Centers for Disease Control and Prevention, (CDC). BILLING CODE 4150–44–P Background and Brief Description Proposed Project DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–0923–0039] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should The Agency for Toxic Substances and Disease Registry (ATSDR) is mandated pursuant to the 1980 Comprehensive Environmental Response Compensation and Liability Act (CERCLA) and its 1986 Amendments, the Superfund Amendments and Re-authorization Act (SARA), to establish and maintain national registries of persons who have been exposed to hazardous substances in the environment and national registries of persons with illnesses or health problems resulting from such exposure. In 2003, ATSDR created the Tremolite Asbestos Registry (TAR) as a result of this legislation in an effort to provide scientific information about potential adverse health effects people develop as a result of exposure to the amphibole fibers that are found in vermiculite mined from Libby, Montana. The purpose of the TAR is to improve communication with people at risk for developing asbestos-related diseases resulting from exposure in Libby, Montana and to support research activities related to TAR registrants. The TAR is currently composed of information about former vermiculite workers, the people that lived with them during their tenure as vermiculite workers (i.e., the workers’ household contacts), and people who participated in screening programs funded by ATSDR conducted in Libby and other sites that received Libby vermiculite. TAR participants are interviewed to collect information on exposure pathways, tobacco use, and health outcomes. The standardized TAR survey is administered using a computerassisted personal interview instrument. There is no cost to the respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Responses per respondent Avg. burden per response (in hrs.) Respondents Forms TAR Participants ............................... Baseline TAR questionnaire ............. Follow-up questionnaire ................... 500 4,500 1 1 30/60 20/60 Total ........................................... ........................................................... ........................ ........................ 1,750 VerDate Nov<24>2008 17:03 May 06, 2009 Jkt 217001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\07MYN1.SGM 07MYN1 Total burden hours 250 1,500

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 74, Number 87 (Thursday, May 7, 2009)]
[Notices]
[Pages 21368-21369]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-10668]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public. Pre-registration is 
required for both public attendance and comment. Individuals who wish 
to attend the meeting and/or participate in the public comment session 
should either e-mail nvpo@hhs.gov or call 202-690-5566 to register.

DATES: The meeting will be held on June 2, 2009, from 9 a.m. to 5:30 
p.m. and on June 3, 2009, from 8:30 a.m. to 1:30 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey

[[Page 21369]]

Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Andrea Krull, Public Health 
Advisor, National Vaccine Program Office, Department of Health and 
Human Services, Room 443-H Hubert H. Humphrey Building, 200 
Independence Avenue, SW., Washington, DC 20201. Phone: (202) 690-5566; 
Fax: (202) 260-1165; e-mail: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program, on matters related to the Program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    Topics to be discussed at the meeting include vaccine safety 
recommendations, the National Vaccine Plan, adult immunization 
recommendations, NVAC evaluation, vaccine stockpile, vaccine financing, 
2009 H1N1 influenza outbreak, and other related issues. The meeting 
agenda will be posted on the Web site: https://www.hhs.gov/nvpo/nvac by 
May 18, 2009.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the designated contact person at least one week prior to the 
meeting. Members of the public will have the opportunity to provide 
comments at the meeting. Public comment will be limited to five minutes 
per speaker. Individuals who would like to submit written statements 
should e-mail or fax their comments to the National Vaccine Program 
Office at least five business days prior to the meeting. Register by 
sending an e-mail to nvpo@hhs.gov or by calling 202-690-5566 and 
providing name, e-mail address and organization.

    Dated: April 29, 2009.
Bruce Gellin,
Deputy Assistant Secretary for Health, Director, National Vaccine 
Program Office.
[FR Doc. E9-10668 Filed 5-6-09; 8:45 am]
BILLING CODE 4150-44-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.